Cargando…

Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer

Ovarian Cancer represents the most fatal type of gynecological malignancies. A number of processes are involved in the pathogenesis of ovarian cancer, especially within the tumor microenvironment. Angiogenesis represents a hallmark phenomenon in cancer, and it is responsible for tumor spread and met...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavalas, Nikos G., Liontos, Michalis, Trachana, Sofia-Paraskevi, Bagratuni, Tina, Arapinis, Calliope, Liacos, Christine, Dimopoulos, Meletios A., Bamias, Aristotle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759892/
https://www.ncbi.nlm.nih.gov/pubmed/23903048
http://dx.doi.org/10.3390/ijms140815885
_version_ 1782282704051503104
author Gavalas, Nikos G.
Liontos, Michalis
Trachana, Sofia-Paraskevi
Bagratuni, Tina
Arapinis, Calliope
Liacos, Christine
Dimopoulos, Meletios A.
Bamias, Aristotle
author_facet Gavalas, Nikos G.
Liontos, Michalis
Trachana, Sofia-Paraskevi
Bagratuni, Tina
Arapinis, Calliope
Liacos, Christine
Dimopoulos, Meletios A.
Bamias, Aristotle
author_sort Gavalas, Nikos G.
collection PubMed
description Ovarian Cancer represents the most fatal type of gynecological malignancies. A number of processes are involved in the pathogenesis of ovarian cancer, especially within the tumor microenvironment. Angiogenesis represents a hallmark phenomenon in cancer, and it is responsible for tumor spread and metastasis in ovarian cancer, among other tumor types, as it leads to new blood vessel formation. In recent years angiogenesis has been given considerable attention in order to identify targets for developing effective anti-tumor therapies. Growth factors have been identified to play key roles in driving angiogenesis and, thus, the formation of new blood vessels that assist in “feeding” cancer. Such molecules include the vascular endothelial growth factor (VEGF), the platelet derived growth factor (PDGF), the fibroblast growth factor (FGF), and the angiopoietin/Tie2 receptor complex. These proteins are key players in complex molecular pathways within the tumor cell and they have been in the spotlight of the development of anti-angiogenic molecules that may act as stand-alone therapeutics, or in concert with standard treatment regimes such as chemotherapy. The pathways involved in angiogenesis and molecules that have been developed in order to combat angiogenesis are described in this paper.
format Online
Article
Text
id pubmed-3759892
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-37598922013-09-03 Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer Gavalas, Nikos G. Liontos, Michalis Trachana, Sofia-Paraskevi Bagratuni, Tina Arapinis, Calliope Liacos, Christine Dimopoulos, Meletios A. Bamias, Aristotle Int J Mol Sci Review Ovarian Cancer represents the most fatal type of gynecological malignancies. A number of processes are involved in the pathogenesis of ovarian cancer, especially within the tumor microenvironment. Angiogenesis represents a hallmark phenomenon in cancer, and it is responsible for tumor spread and metastasis in ovarian cancer, among other tumor types, as it leads to new blood vessel formation. In recent years angiogenesis has been given considerable attention in order to identify targets for developing effective anti-tumor therapies. Growth factors have been identified to play key roles in driving angiogenesis and, thus, the formation of new blood vessels that assist in “feeding” cancer. Such molecules include the vascular endothelial growth factor (VEGF), the platelet derived growth factor (PDGF), the fibroblast growth factor (FGF), and the angiopoietin/Tie2 receptor complex. These proteins are key players in complex molecular pathways within the tumor cell and they have been in the spotlight of the development of anti-angiogenic molecules that may act as stand-alone therapeutics, or in concert with standard treatment regimes such as chemotherapy. The pathways involved in angiogenesis and molecules that have been developed in order to combat angiogenesis are described in this paper. Molecular Diversity Preservation International (MDPI) 2013-07-30 /pmc/articles/PMC3759892/ /pubmed/23903048 http://dx.doi.org/10.3390/ijms140815885 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland http://creativecommons.org/licenses/by/3.0 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Gavalas, Nikos G.
Liontos, Michalis
Trachana, Sofia-Paraskevi
Bagratuni, Tina
Arapinis, Calliope
Liacos, Christine
Dimopoulos, Meletios A.
Bamias, Aristotle
Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer
title Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer
title_full Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer
title_fullStr Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer
title_full_unstemmed Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer
title_short Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer
title_sort angiogenesis-related pathways in the pathogenesis of ovarian cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759892/
https://www.ncbi.nlm.nih.gov/pubmed/23903048
http://dx.doi.org/10.3390/ijms140815885
work_keys_str_mv AT gavalasnikosg angiogenesisrelatedpathwaysinthepathogenesisofovariancancer
AT liontosmichalis angiogenesisrelatedpathwaysinthepathogenesisofovariancancer
AT trachanasofiaparaskevi angiogenesisrelatedpathwaysinthepathogenesisofovariancancer
AT bagratunitina angiogenesisrelatedpathwaysinthepathogenesisofovariancancer
AT arapiniscalliope angiogenesisrelatedpathwaysinthepathogenesisofovariancancer
AT liacoschristine angiogenesisrelatedpathwaysinthepathogenesisofovariancancer
AT dimopoulosmeletiosa angiogenesisrelatedpathwaysinthepathogenesisofovariancancer
AT bamiasaristotle angiogenesisrelatedpathwaysinthepathogenesisofovariancancer